The IPO of Nightingale has been oversubscribed and the listing will be completed as planned – trading in the series B shares is expected to commence on 19 March 2021
Company Release18 March 2021 7:00 p.m. (Finnish time) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Nightingale Health Plc (“Nightingale” or the “Company”) announces the outcome of the initial public offering of its series B shares (the “Shares”) on Nasdaq First North Growth Market Finland (the “IPO” or the “Offering”). The Offering attracted strong interest from global and